Alteplase (rtPA)
Alteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction and PE
Alteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction and PE
Amiodarone: class III anti-arrhythmic; prolongs cardiac action potential & delaying refractory period
Aprotinin: antifibrinolytic; single chain polypeptide which occurs naturally in bovine lung and other tissues; inhibits fibrionlysis via inactivation of free plasmin
Aspirin: antiplatelet agent; irreversible acetylation of cyclooxygenase -> blocks the production of prostaglandins from membrane phospholipids -> inactivation of platelet aggregation by arachidonic acid and collagen.
Benzylpenicillin: penicillin antibiotic; inhibition of cell wall synthesis
Bosentan: dual endothelin receptor antagonist; competitive antagonism of endothelin-1 (pulmonary vasoconstrictor) at the endothelin receptors -> decreases PVR
Ceftriaxone: 3rd generation cephalosporin; inhibition of cell wall synthesis: gram –ve rods (except Pseudomonas); gram +ve cocci (except Methicillin resistant and group D streptococci)
Spironolactone: Potassium sparing diuretic; aldosterone blockade
Classification of Vasoactive Drugs
Oculocephalic and oculovestibular reflexes are primarily used to determine whether a patient's brainstem is intact (e.g. coma or brain death assessment)
Guillain-Barré Syndrome (GBS) is the most common and most severe acute paralytic neuropathy, consisting of multiple variants with distinct clinical and pathological features
Hearing Loss in ICU is an under-appreciated problem: Conductive (external ear; middle and inner ear; Sensorineural)